Antibiotic resistance in neonates in China 2012–2019: A multicenter study

2018 Xiao, 2013, Changes in Chinese policies to promote the rational use of antibiotics, PLoS Med, 10, 10.1371/journal.pmed.1001556 Xiao, 2012, Mohnarin report of 2011: monitoring of bacterial resistance in China [in Chinese], Chin J Nosocomiol, 22, 4946 Zhang, 2006, Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States, Glob Health, 2, 6, 10.1186/1744-8603-2-6 Li, 2012, Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids, Health Aff, 31, 1075, 10.1377/hlthaff.2010.0965 Xiao, 2011, Epidemiology and characteristics of antimicrobial resistance in China, Drug Resist Updates, 14, 236, 10.1016/j.drup.2011.07.001 Wang, 2015, Antibiotic body burden of Chinese school children: a multisite biomonitoring-based study, Environ Sci Technol, 49, 5070, 10.1021/es5059428 Landrigan, 1995, Environmental policy andchildren's health, Future Child, 5, 34, 10.2307/1602356 Tregoning, 2010, Respiratory viral infections ininfants: causes, clinical symptoms, virology, and immunology, Clin Microbiol Rev, 23, 74, 10.1128/CMR.00032-09 Greenhow, 2012, Changing epidemiology of bacteremia in infants aged 1 week to 3 months, Pediatrics, 129, e590, 10.1542/peds.2011-1546 Kerrn, 2002, Susceptibility of Danish Escherichia coli strains isolated from urinary tract infections and bacteraemia, and distribution of sul genes conferring sulphonamide resistance, J Antimicrob Chemother, 50, 513, 10.1093/jac/dkf164 2014 Laxminarayan, 2016, Access to effective antimicrobials: a worldwide challenge, Lancet, 387, 168, 10.1016/S0140-6736(15)00474-2 Liu, 2015, Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis, Lancet, 385, 430, 10.1016/S0140-6736(14)61698-6 WHO, 2014 Cruz, 2017, Accuracy of complete blood cell counts to identify febrile infants 60 Days or younger with invasive bacterial infections, JAMA Pediatr, 171, 10.1001/jamapediatrics.2017.2927 Heath, 2003, Neonatal meningitis, Arch Dis Child Fetal Neonatal Ed, 88, F173, 10.1136/fn.88.3.F173 Seale, 2009, Maternal and early onset neonatal bacterial sepsis: burden and strategies for prevention in sub-Saharan Africa, Lancet Infect Dis, 9, 428, 10.1016/S1473-3099(09)70172-0 Bekker, 2014, Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in The Netherlands over 25 years: a nationwide surveillance study, Lancet Infect Dis, 14, 1083, 10.1016/S1473-3099(14)70919-3 2013 Phares, 2008, Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005, J Am Med Assoc, 299, 2056, 10.1001/jama.299.17.2056 Stoll, 2011, Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues, Pediatrics, 127, 817, 10.1542/peds.2010-2217 Glasgow, 2005, Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants, Pediatrics, 116, 696, 10.1542/peds.2004-2421 Park, 2011, Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes, Microb Drug Resist, 17, 537, 10.1089/mdr.2011.0072 Livermore, 2012, Current epidemiology and growing resistance of Gram-negative pathogens, Korean J Intern Med (Korean Ed), 27, 128, 10.3904/kjim.2012.27.2.128 da Costa, 2013, Transfer of multidrug-resistant bacteria between intermingled ecological niches: the interface between humans, animals and the environment, Int J Environ Res Public Health, 10, 278, 10.3390/ijerph10010278 Paterson, 2005, Extended-spectrum β-lactamases: a clinical update, Clin Microbiol Rev, 18, 657, 10.1128/CMR.18.4.657-686.2005 Livermore, 2007, CTX-M: changing the face of ESBLs in Europe, J Antimicrob Chemother, 59, 165, 10.1093/jac/dkl483 Bradford, 2001, Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat, Clin Microbiol Rev, 14, 933, 10.1128/CMR.14.4.933-951.2001 Quan, 2017, High prevalence of ESBL-producingEscherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China, J Antimicrob Chemother, 72, 273, 10.1093/jac/dkw372 Dong, 2008, Antibiotic prescribing patterns in village healthclinics across 10 provinces of Western China, J Antimicrob Chemother, 62, 410, 10.1093/jac/dkn153 Zhu, 2019, Escherichia coliMulti-drug resistant CausingEarly-onset neonatal sepsis - a single center experience from China, Infect Drug Resist, 12, 3695, 10.2147/IDR.S229799 Goldman, 2004, Antibiotic abuse in animal agriculture: exacerbating drug resistance in human pathogens, Hum Ecol Risk Assess, 10, 121, 10.1080/10807030490281016 Alsan, 2015, Out-of-pocket health expenditures and antimicrobial resistance in low-income and middle-income countries: an economic analysis, Lancet Infect Dis, 15, 1203, 10.1016/S1473-3099(15)00149-8 Van Boeckel, 2015, Global trends in antimicrobialuse in food animals, Proc Natl Acad Sci USA, 112, 5649, 10.1073/pnas.1503141112 Littmann, 2015, The ethical significance of antimicrobial resistance, Publ Health Ethics, 8, 209 2012 2016 Wang, 2019, Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010-2016: a retrospective observational study, BMJ Open, 9 2016 2018 Li, 2020, Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network, Arch Dis Child, 105, 26, 10.1136/archdischild-2019-316816 Bizzarro, 2008, Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis, Pediatrics, 121, 689, 10.1542/peds.2007-2171